US Stock MarketDetailed Quotes

CTNM Contineum Therapeutics

Watchlist
  • 14.410
  • +0.270+1.91%
Close Dec 24 13:00 ET
371.46MMarket Cap-12.83P/E (TTM)

Contineum Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Contineum Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
--------

Unlock Free Earnings Estimates

Contineum Therapeutics Earnings Reports

  • Contineum Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 6 16:16 ET

  • Contineum Therapeutics | 8-K: Contineum Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

    Nov 6 16:14 ET

  • Contineum Therapeutics | 10-Q: Quarterly report

    Aug 14 12:50 ET

  • Contineum Therapeutics | 8-K/A: Contineum Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

    Aug 14 12:25 ET

    • Read more

    Trending US Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Ermenegildo Zegna NV
    ZGN
    +1.41%
    Workday
    WDAY
    +1.38%
    Dorian LPG
    LPG
    +1.12%
    DexCom
    DXCM
    +0.88%
    Precision Drilling
    PDS
    +0.86%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Nov 30, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data